LGVN: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	398,000	137,000	316,000	381,000	773,000	468,000
Cost of revenue	134,000	12,000	170,000	106,000	91,000	124,000
Gross profit	264,000	125,000	146,000	275,000	682,000	344,000
Research and development	2M	4M	3M	3M	2M	2M
Selling, general and administrative	3M	4M	3M	3M	3M	2M
Operating expenses	5M	7M	6M	5M	5M	4M
Operating income	−5M	−7M	−5M	−5M	−5M	−4M
Net income	−5M	−7M	−5M	−5M	−4M	−3M
Earnings per share	−0.19	−0.39	−0.33	−0.34	−0.34	−1.83
Earnings per share, diluted	−0.19	−0.39	−0.33	−0.34	−0.34	−1.83
Weighted average shares	24.79B	18.37B	15.01B	14.95B	13.63B	6.51B
Weighted average shares, diluted	24.79B	18.37B	15.01B	14.95B	13.63B	6.51B

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	16M	5M	9M	10M	14M	19M	23M	12M
Short-term investments	—	—	—	—	—	0	0	—
Receivables	68,000	104,000	52,000	31,000	29,000	84,000	380,000	218,000
Current assets	17M	5M	10M	11M	15M	20M	24M	13M
Property, plant and equipment	2M	2M	2M	2M	2M	2M	3M	2M
Total assets	21M	10M	16M	17M	21M	26M	30M	19M
Current liabilities	4M	4M	5M	3M	3M	3M	3M	3M
Total liabilities	5M	5M	6M	4M	4M	4M	4M	4M
Equity	16M	6M	10M	13M	17M	22M	26M	15M

Metric	31/03/2026	31/03/2025
Operating cash flow	−4M	−5M
Depreciation and amortisation	252,000	421,000
Share-based compensation	379,000	340,000
Capital expenditure	0	27,000
Investing cash flow	−20,000	−150,000
Financing cash flow	15M	−58,000